Clinica Baviera S.A.
Common Stock · EUR · BME
Price
€58.4
Cap
—
Earnings
—
30d Trend
+7.7%
28% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 68×Macro 0.99 (−1%)=67
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month momentum thesis — strong trend with confirmation
BRAIN47'S ASSESSMENT
I rate Clinica Baviera S.A. at 67/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 86/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+4.9%
3 MONTHS
+6.9%
12 MONTHS
+48.6%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month momentum thesis — strong trend with confirmation. Momentum (86) and Quality (76) are the primary strengths. Historical volatility is moderate at 28%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.